Rachel K. King - 12 Nov 2024 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
Director
Signature
/s/ Alan Musso as attorney-in-fact for Rachel King
Issuer symbol
FULC
Transactions as of
12 Nov 2024
Net transactions value
$0
Form type
4
Filing time
14 Nov 2024, 16:15:03 UTC
Previous filing
14 Jun 2024
Next filing
02 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Award $0 +60,000 $0.000000 60,000 12 Nov 2024 Common Stock 60,000 $3.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on November 12, 2024 and is scheduled to vest in equal monthly installments until November 12, 2027, subject to continued service.